232 related articles for article (PubMed ID: 29398868)
1. Overexpression of CREPT confers colorectal cancer sensitivity to fluorouracil.
Kuang YS; Wang Y; Ding LD; Yang L; Wang Y; Liu SH; Zhu BT; Wang XN; Liu HY; Li J; Chang ZJ; Wang YY; Jia BQ
World J Gastroenterol; 2018 Jan; 24(4):475-483. PubMed ID: 29398868
[TBL] [Abstract][Full Text] [Related]
2. High expression of CREPT promotes tumor growth and is correlated with poor prognosis in colorectal cancer.
Zheng G; Li W; Zuo B; Guo Z; Xi W; Wei M; Chen P; Wen W; Yang AG
Biochem Biophys Res Commun; 2016 Nov; 480(3):436-442. PubMed ID: 27773816
[TBL] [Abstract][Full Text] [Related]
3. CREPT facilitates colorectal cancer growth through inducing Wnt/β-catenin pathway by enhancing p300-mediated β-catenin acetylation.
Zhang Y; Wang S; Kang W; Liu C; Dong Y; Ren F; Wang Y; Zhang J; Wang G; To KF; Zhang X; Sung JJ; Chang Z; Yu J
Oncogene; 2018 Jun; 37(26):3485-3500. PubMed ID: 29563608
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targeting BIRC5.
Li PL; Zhang X; Wang LL; Du LT; Yang YM; Li J; Wang CX
Carcinogenesis; 2015 Dec; 36(12):1484-93. PubMed ID: 26442524
[TBL] [Abstract][Full Text] [Related]
5. Cell cycle-related and expression-elevated protein in tumor overexpression is associated with proliferation behaviors and poor prognosis in non-small-cell lung cancer.
Li W; Zheng G; Xia J; Yang G; Sun J; Wang X; Wen M; Sun Y; Zhang Z; Jin F
Cancer Sci; 2018 Apr; 109(4):1012-1023. PubMed ID: 29397041
[TBL] [Abstract][Full Text] [Related]
6. XRCC2-Deficient Cells are Highly Sensitive to 5-Fluorouracil in Colorectal Cancer.
Zhang YZ; An JH; Liu YX; Wu XC; Han SS; Ren XQ; Qin CJ
Cell Physiol Biochem; 2017; 43(3):1207-1219. PubMed ID: 28977800
[TBL] [Abstract][Full Text] [Related]
7. Esculetin enhances the inhibitory effect of 5-Fluorouracil on the proliferation, migration and epithelial-mesenchymal transition of colorectal cancer.
Yan L; Yu HH; Liu YS; Wang YS; Zhao WH
Cancer Biomark; 2019; 24(2):231-240. PubMed ID: 30689555
[TBL] [Abstract][Full Text] [Related]
8. 5-Fluorouracil induced Fas upregulation associated with apoptosis in liver metastases of colorectal cancer patients.
Backus HH; Dukers DF; van Groeningen CJ; Vos W; Bloemena E; Wouters D; van Riel JM; Smid K; Giaccone G; Pinedo HM; Peters GJ
Ann Oncol; 2001 Feb; 12(2):209-16. PubMed ID: 11300326
[TBL] [Abstract][Full Text] [Related]
9. Loss of Smad4 in colorectal cancer induces resistance to 5-fluorouracil through activating Akt pathway.
Zhang B; Zhang B; Chen X; Bae S; Singh K; Washington MK; Datta PK
Br J Cancer; 2014 Feb; 110(4):946-57. PubMed ID: 24384683
[TBL] [Abstract][Full Text] [Related]
10. Knocking-down of CREPT prohibits the progression of oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc expression.
Ma J; Ren Y; Zhang L; Kong X; Wang T; Shi Y; Bu R
PLoS One; 2017; 12(4):e0174309. PubMed ID: 28369091
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol Chemosensitizes TNF-β-Induced Survival of 5-FU-Treated Colorectal Cancer Cells.
Buhrmann C; Yazdi M; Popper B; Shayan P; Goel A; Aggarwal BB; Shakibaei M
Nutrients; 2018 Jul; 10(7):. PubMed ID: 30002278
[No Abstract] [Full Text] [Related]
12. FANCJ expression predicts the response to 5-fluorouracil-based chemotherapy in MLH1-proficient colorectal cancer.
Nakanishi R; Kitao H; Fujinaka Y; Yamashita N; Iimori M; Tokunaga E; Yamashita N; Morita M; Kakeji Y; Maehara Y
Ann Surg Oncol; 2012 Oct; 19(11):3627-35. PubMed ID: 22526901
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase 7 is a useful marker for 5-fluorouracil-based adjuvant chemotherapy in stage II and stage III colorectal cancer patients.
Huang Y; Yu H; Lei H; Xie C; Zhong Y
Med Oncol; 2014 Mar; 31(3):824. PubMed ID: 24469951
[TBL] [Abstract][Full Text] [Related]
14. The long non-coding RNA HOTAIRM1 suppresses cell progression via sponging endogenous miR-17-5p/ B-cell translocation gene 3 (BTG3) axis in 5-fluorouracil resistant colorectal cancer cells.
Ren T; Hou J; Liu C; Shan F; Xiong X; Qin A; Chen J; Ren W
Biomed Pharmacother; 2019 Sep; 117():109171. PubMed ID: 31261026
[TBL] [Abstract][Full Text] [Related]
15. STAT5a-targeting miRNA enhances chemosensitivity to cisplatin and 5-fluorouracil in human colorectal cancer cells.
Hong X; Chen G; Wang M; Lou C; Mao Y; Li Z; Zhang Y
Mol Med Rep; 2012 May; 5(5):1215-9. PubMed ID: 22367509
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of HOXA10 Protein Expression Predicts Poor Prognosis for Colorectal Cancer.
Yuan Y; Sun S; Jiao N; Shu Y; Zhang Y
Genet Test Mol Biomarkers; 2018 Jun; 22(6):390-397. PubMed ID: 29870276
[TBL] [Abstract][Full Text] [Related]
17. Pseudolaric acid B induces mitotic arrest and apoptosis in both 5-fluorouracil-sensitive and -resistant colorectal cancer cells.
Wen C; Chen J; Zhang D; Wang H; Che J; Qin Q; He L; Cai Z; Lin M; Lou Q; Huang L; Chen D; Iwamoto A; Ren D; Wang L; Lan P; Wang J; Liu H; Yang X
Cancer Lett; 2016 Dec; 383(2):295-308. PubMed ID: 27713084
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-149 Increases the Sensitivity of Colorectal Cancer Cells to 5-Fluorouracil by Targeting Forkhead Box Transcription Factor FOXM1.
Liu X; Xie T; Mao X; Xue L; Chu X; Chen L
Cell Physiol Biochem; 2016; 39(2):617-29. PubMed ID: 27415661
[TBL] [Abstract][Full Text] [Related]
19. FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10.
Xie T; Geng J; Wang Y; Wang L; Huang M; Chen J; Zhang K; Xue L; Liu X; Mao X; Chen Y; Wang Q; Dai T; Ren L; Yu H; Wang R; Chen L; Chen C; Chu X
Oncotarget; 2017 Jan; 8(5):8574-8589. PubMed ID: 28051999
[TBL] [Abstract][Full Text] [Related]
20. Nuclear orphan receptor NR4A2 confers chemoresistance and predicts unfavorable prognosis of colorectal carcinoma patients who received postoperative chemotherapy.
Han Y; Cai H; Ma L; Ding Y; Tan X; Liu Y; Su T; Yu Y; Chang W; Zhang H; Fu C; Cao G
Eur J Cancer; 2013 Nov; 49(16):3420-30. PubMed ID: 23809767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]